Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 64%
Hold 0%
Sell 0%
Strong Sell 9%

Bulls say

HealthEquity is well-positioned in the fragmented HSA market with its digital platform and offerings that appeal to both consumers and employers. Its strong focus on technology and AI investments is expected to drive margin expansion and allow for continued outperformance in the market. Regulatory tailwinds, such as the potential for HSA eligibility expansion, could also provide opportunities for the company to increase its market share. Overall, the stock has potential for future growth and is currently trading at a discount compared to its historical valuations, making it an attractive investment opportunity.

Bears say

HealthEquity is facing a challenging environment as the labor market weakens, potentially leading to slower growth in HSA balances. Additionally, competition in the healthcare savings industry could increase as alternative payment methods gain popularity. However, HealthEquity has a strong track record of outpacing market growth and has shown resilience during past recessionary periods. But risks still remain, including potential cyber-security attacks and changes in the regulatory environment.

HealthEquity (HQY) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 64% recommend Buy, 0% suggest Holding, 0% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 11 analysts, HealthEquity (HQY) has a Buy consensus rating as of Jul 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $113.91, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $113.91, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.